Ohri N, Shen X, Dicker AP, Doyle LA, Harrison AS, Showalter TN. Radiotherapy protocol deviations and clinical outcomes: a meta-analysis of cooperative group clinical trials. 2013 [cited 2020 Aug 10]. https://academic.oup.com/jnci/article/105/6/387/1021035
Peters LJ, O’Sullivan B, Giralt J, Fitzgerald TJ, Trotti A, Bernier J, et al. Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: Results from TROG 02.02. J Clin Oncol. [Internet]. 2010 [cited 2020 Aug 10];28(18):2996–3001. https://pubmed.ncbi.nlm.nih.gov/20479390/
Fairchild A, Straube W, Laurie F, Followill D. Does quality of radiation therapy predict outcomes of multicenter cooperative group trials? A literature review [Internet]. Vol. 87, International Journal of Radiation Oncology Biology Physics. Int J Radiat Oncol Biol Phys.; 2013 [cited 2020 Aug 10]. p. 246–60. https://pubmed.ncbi.nlm.nih.gov/23683829/
Kron T, Chesson B, Hardcastle N, Crain M, Clements N, Burns M, et al. Credentialing of radiotherapy centres in Australasia for TROG 09.02 (Chisel), a Phase III clinical trial on stereotactic ablative body radiotherapy of early stage lung cancer. Br J Radiol. [Internet]. 2018 [cited 2019 Sep 11];91(1085):20170737. http://www.ncbi.nlm.nih.gov/pubmed/29446317
Ball D, Mai GT, Vinod S, Babington S, Ruben J, Kron T, et al. Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial. Lancet Oncol. [Internet]. 2019 [cited 2019 Jun 12];20(4):494–503. https://linkinghub.elsevier.com/retrieve/pii/S1470204518308969
Siva S, Chesson B, Bressel M, Pryor D, Higgs B, Reynolds HM, et al. TROG 15.03 phase II clinical trial of Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney—FASTRACK II 11 Medical and Health Sciences 1103 Clinical Sciences 11 Medical and Health Sciences 1112 Oncology and Carcinogenesis. BMC Cancer [Internet]. 2018 [cited 2019 Jun 12];18(1):1030. http://www.ncbi.nlm.nih.gov/pubmed/30352550
Siva S, Correa RJM, Warner A, Staehler M, Ellis RJ, Ponsky L, et al. Stereotactic ablative radiotherapy for ≥T1b primary renal cell carcinoma: a report from the International Radiosurgery Oncology Consortium for Kidney (IROCK). Int J Radiat Oncol Biol Phys. 2020;108:941–9.
Siva S, Jackson P, Kron T, Bressel M, Lau E, Hofman M, et al. Impact of stereotactic radiotherapy on kidney function in primary renal cell carcinoma: establishing a dose-response relationship. Radiother Oncol. 2016;118(3):540–6.
Pham D, Kron T, Bressel M, Foroudi F, Hardcastle N, Schneider M, et al. Image guidance and stabilization for stereotactic ablative body radiation therapy (SABR) treatment of primary kidney cancer. Pract Radiat Oncol. 2015;5(6):e597-605.
Li N, Carmona R, Sirak I, Kasaova L, Followill D, Michalski J, et al. Highly efficient training, refinement, and validation of a knowledge-based planning quality-control system for radiation therapy clinical trials. Int J Radiat Oncol Biol Phys. 2017;97(1):164–72.
Moore KL, Brame RS, Low DA, Mutic S. Experience-based quality control of clinical intensity-modulated radiotherapy planning. Int J Radiat Oncol Biol Phys [Internet]. 2011 [cited 2020 Aug 18];81(2):545–51. https://pubmed.ncbi.nlm.nih.gov/21277097/
Appenzoller LM, Michalski JM, Thorstad WL, Mutic S, Moore KL. Predicting dose-volume histograms for organs-at-risk in IMRT planning. Med Phys [Internet]. 2012 [cited 2020 Aug 18];39(12):7446–61. https://pubmed.ncbi.nlm.nih.gov/23231294/
Kavanaugh JA, Holler S, DeWees TA, Robinson CG, Bradley JD, Iyengar P, et al. Multi-institutional validation of a knowledge-based planning model for patients enrolled in RTOG 0617: implications for plan quality controls in cooperative group trials. Pract Radiat Oncol. 2019;9(2):e218–27.
Tol JP, Delaney AR, Dahele M, Slotman BJ, Verbakel WFAR. Evaluation of a knowledge-based planning solution for head and neck cancer. Int J Radiat Oncol Biol Phys. 2015;91(3):612–20. https://doi.org/10.1016/j.ijrobp.2014.11.014.
Tol JP, Dahele M, Gregoire V, Overgaard J, Slotman BJ, Verbakel WFAR. Analysis of EORTC-1219-DAHANCA-29 trial plans demonstrates the potential of knowledge-based planning to provide patient-specific treatment plan quality assurance. Radiother Oncol [Internet]. 2019 [cited 2020 Aug 18];130:75–81. http://www.thegreenjournal.com/article/S0167814018335102/fulltext
Giaddui T, Geng H, Chen Q, Linnemann N, Radden M, Lee NY, et al. Offline quality assurance for intensity modulated radiation therapy treatment plans for NRG-HN001 head and neck clinical trial using knowledge-based planning. Adv Radiat Oncol [Internet]. 2020. https://doi.org/10.1016/j.adro.2020.05.005
Younge KC, Marsh RB, Owen D, Geng H, Xiao Y, Spratt DE, et al. Improving quality and consistency in NRG oncology RTOG 0631 for spine radiosurgery via knowledge-based planning. Int J Radiat Oncol [Internet]. 2018. http://www.sciencedirect.com/science/article/pii/S0360301617345029
Panettieri V, Ball D, Chapman A, Cristofaro N, Gawthrop J, Griffin P, et al. Development of a multicentre automated model to reduce planning variability in radiotherapy of prostate cancer. Phys Imaging Radiat Oncol [Internet]. 2019;11:34–40. https://linkinghub.elsevier.com/retrieve/pii/S2405631619300259
Berry SL, Ma R, Boczkowski A, Jackson A, Zhang P, Hunt M. Evaluating inter-campus plan consistency using a knowledge based planning model. Radiother Oncol. 2016;120(2):349–55.
Good D, Lo J, Lee WR, Wu QJ, Yin FF, Das SK. A knowledge-based approach to improving and homogenizing intensity modulated radiation therapy planning quality among treatment centers: an example application to prostate cancer planning. Int J Radiat Oncol Biol Phys. 2013;87(1):176–81. https://doi.org/10.1016/j.ijrobp.2013.03.015.
Ge Y, Wu QJ. Knowledge‐based planning for intensity‐modulated radiation therapy: A review of data‐driven approaches. Med Phys [Internet]. 2019 [cited 2020 Sep 18];46(6):2760–75. https://onlinelibrary.wiley.com/doi/abs/10.1002/mp.13526
Tol JP, Dahele M, Gregoire V, Overgaard J, Slotman BJ, Verbakel WFAR. Analysis of EORTC-1219-DAHANCA-29 trial plans demonstrates the potential of knowledge-based planning to provide patient-specific treatment plan quality assurance. Radiother Oncol. 2019;1(130):75–81.
Tol JP, Dahele M, Delaney AR, Slotman BJ, Verbakel WFAR. Can knowledge-based DVH predictions be used for automated, individualized quality assurance of radiotherapy treatment plans? Radiat Oncol. 2015;10(1):1–14. https://doi.org/10.1186/s13014-015-0542-1.
Moore KL, Schmidt R, Moiseenko V, Olsen LA, Tan J, Xiao Y, et al. Quantifying unnecessary normal tissue complication risks due to suboptimal planning: a secondary study of RTOG 0126. Int J Radiat Oncol Biol Phys [Internet]. 2015 [cited 2020 Aug 10];92(2):228–35. https://pubmed.ncbi.nlm.nih.gov/25847605/
Siva S, Pham D, Kron T, Bressel M, Lam J, Tan TH, et al. Stereotactic ablative body radiotherapy for inoperable primary kidney cancer: a prospective clinical trial. BJU Int [Internet]. 2017 [cited 2020 Aug 21];120(5):623–30. https://pubmed.ncbi.nlm.nih.gov/28188682/
Yusufaly TI, Meyers SM, Mell LK, Moore KL. Knowledge-Based Planning for Intact Cervical Cancer. Vol. 30, Seminars in Radiation Oncology. W.B. Saunders; 2020. p. 328–39.
Knutson NC, Samson P, Hugo G, Goddu SM, Reynoso F, Kavanaugh J, et al. Radiotherapy Workflow and Dosimetric Analysis from a Phase I/II Trial of Noninvasive Cardiac Radioablation for Ventricular Tachycardia. Int J Radiat Oncol [Internet]. 2019 [cited 2019 May 12]. http://www.ncbi.nlm.nih.gov/pubmed/31002942
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.